agilon health, inc. Common Stock (AGL)

agilon health, inc. (NYSEAGL), the trusted partner empowering physicians to transform health care in our communities, announced that its Accountable Care Organizations (ACOs) achieved $150 million in gross savings (13% gross savings rate), including $37 million savings to the Medicare Trust Fund, during the 2023 performance year of the ACO Realizing Equity, Access and Community Health (ACO REACH) model. agilon’s eight REACH ACOs operate under full risk, and in 2023 were responsible for the total cost and quality of care for approximately 90,000 Traditional Medicare beneficiaries.

agilon health, inc. (NYSEAGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the third quarter ended September 30, 2024.

agilon health, inc. (NYSEAGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 2024 Wolfe Research Healthcare Conference including a fireside chat presentation on Tuesday, November 19, at 2:20 PM Eastern Time.

NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. (NYSEAGL) on behalf of long-term stockholders following a class action complaint that was filed against Agilon on March 19, 2024 with Class Period (1) Agilon common stock purchases traceable to the April 2021 initial public offering of Agilon stock; (2) pursuant, or traceable, or both, to materials issued in connection with the Company’s secondary public offering that occurred on or about May 16, 2023; and/or (3) common stock between April 15, 2021 and February 27, 2024. Our investigation concerns whether the board of directors of Agilon have breached their fiduciary duties to the company.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into agilon health, inc. (“agilon” or the “Company”) (NYSEAGL).

agilon health, inc. (NYSEAGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the third quarter 2024 after the market closes on Thursday, November 7, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into agilon health, inc. (“agilon” or the “Company”) (NYSEAGL).

agilon health, inc. (NYSEAGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 2024 Wells Fargo Healthcare Conference, including a fireside chat presentation on Wednesday, September 4, at 3:00 PM Eastern Time.

NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc. (NYSEAGL) on behalf of long-term stockholders following a class action complaint that was filed against Agilon on March 19, 2024 with Class Period (1) Agilon common stock purchases traceable to the April 2021 initial public offering of Agilon stock; (2) pursuant, or traceable, or both, to materials issued in connection with the Company’s secondary public offering that occurred on or about May 16, 2023; and/or (3) common stock between April 15, 2021 and February 27, 2024. Our investigation concerns whether the board of directors of Agilon have breached their fiduciary duties to the company.

agilon health, inc. (NYSEAGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the second quarter ended June 30, 2024.

agilon health, inc. (NYSEAGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2024 after the market closes on Tuesday, August 6, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results.

agilon health, inc. (NYSEAGL), the trusted partner empowering physicians to transform health care in our communities, announced today that after a comprehensive search Karthik Rao, M.D., who has served as agilon’s interim chief medical officer (CMO) since February 2024, has been appointed to the permanent CMO role, effective immediately. He previously served as senior medical director and vice president, network performance, at the company.

agilon health, inc. (NYSEAGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Jeff Schwaneke, an experienced finance, operational and managed care executive and director on agilon’s board, will join the Company as chief financial officer and executive vice president effective July 1, 2024. He will be a member of agilon’s Executive Leadership team reporting to chief executive officer (CEO), Steve Sell. Schwaneke succeeds Timothy Bensley, who announced his retirement from agilon in early 2024. Bensley has agreed to stay on through a transition period.

agilon health, inc. (NYSEAGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 44th Annual William Blair Growth Stock Conference including a presentation on Wednesday, June 5, at 12:20 PM Eastern Time.

LOS ANGELES, May 14, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. (“agilon” or “the Company”) (NYSEAGL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

NEW YORK, NY - (NewMediaWire) - May 9, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of agilon health, Inc. (“agilon” or the “Company”) (NYSEAGL) common stock between April 15, 2021 and February 27, 2024. Click Here to Join Investigation.

NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against agilon health, inc. (“agilon” or the “Company”) (NYSEAGL) and reminds investors of the May 20, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

agilon health, inc. (NYSEAGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the first quarter ended March 31, 2024.

agilon health (NYSEAGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it has formed long-term partnerships with five new physician practices across the U.S. to enable their transition to a full-risk, value-based care model. Recognized leaders in their respective communities, the new partners include Graves Gilbert Clinic in Kentucky, Mankato Clinic in Minnesota, Springfield Clinic in Illinois, and Twin Cities Network in Minnesota, as well as an independent, multi-specialty practice in North Carolina to be named at a later date.

LOS ANGELES, May 07, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. (“agilon” or “the Company”) (NYSEAGL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

NEW YORK, May 01, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against agilon health, inc. (“agilon” or the “Company”) (NYSEAGL) and reminds investors of the May 20, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. (NYSEAGL) (“agilon” or the “Company”). This action, captioned Hope v. agilon health, inc., et al., Case No. 1:24-cv-00305, was filed in the United States District Court for the Western District of Texas and expanded the class period which was pled in a first-filed case in that same Court. After the Hope action was filed, another case was filed against agilon in another Court, the United States District Court for the Southern District of New York, which even further expanded the class period as pled in the Hope action as that case is brought on behalf of investors who purchased or acquired agilon common stock between April 15, 2021, and February 27, 2024, inclusive (the “Class Period”).

SAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) --

LOS ANGELES, April 23, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against agilon health, inc. (“agilon” or “the Company”) (NYSEAGL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.